Is this you? Create Your Porfile
Avatar

Phillip J. Johnson

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Phillip J. Johnson is active.

Explore More

Publication

Featured researches published by Phillip J. Johnson.

Organic Process Research & Development | 2005

Evaluation of kilogram-scale Sonagashira, Suzuki, and Heck coupling routes to oncology candidate CP-724,714

David H. Brown Ripin; Dennis E. Bourassa; Thomas A. Brandt; Michael J. Castaldi; Heather N. Frost; Joel M. Hawkins; Phillip J. Johnson; Stephen S. Massett; Karin Neumann; James Phillips; Jeffery W. Raggon; Peter Robert Rose; Jennifer L. Rutherford; Barbara J. Sitter; A. Morgan Stewart; Michael G. Vetelino; Lulin Wei

Archive | 1995

Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt

Lynne A. Handanyan; Thomas Arthus Morris; Robert L. Hendrickson; Phillip J. Johnson; Timothy Norris

Archive | 2002

Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Phillip J. Johnson; Peter Robert Rose; Glenn Robert Williams; Lewin Theophilus Wint

Archive | 2002

The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Phillip J. Johnson; Peter Robert Rose; Lewin Theophilus Wint; Glenn Robert Williams

Archive | 2012

Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer

Brendan John Murphy; Timothy D. White; Brian P. Chekal; Phillip J. Johnson; Christopher James Foti; Leonid A. Margulis

Archive | 2003

Process for the preparation of 1,3-substituted indenes

Robert Eugene Handfield; Timothy J. N. Watson; Phillip J. Johnson; Peter Robert Rose

Archive | 2004

Citrate salt of 5,8,14-triazatetracyclo&lsqb 10.3.1.02,11.04,9&rsqb -hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Phillip J. Johnson; Peter Robert Rose; Glenn Robert Williams; Lewin Theophilus Wint

Archive | 2003

Improved process for the preparation of 1,3-substituted indenes

Robert Eugene Handfield; Phillip J. Johnson; Peter Robert Rose; Timothy J. N. Watson

Archive | 2012

CRYSTALLINE PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS

Brendan John Murphy; Timothy D. White; Brian P. Chekal; Phillip J. Johnson; Christopher James Foti; Leonid A. Margulis

Archive | 2012

Pharmaceutical composition comprising tofacitinib and a penetration enhancer

Brendan John Murphy; Timothy D. White; Brian P. Chekal; Phillip J. Johnson; Christopher James Foti; Leonid A. Margulis

Explore More

Collaboration

Dive into the Phillip J. Johnson's collaboration.

Top Co-Authors
Avatar

Peter Robert Rose

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Brendan John Murphy

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Brian P. Chekal

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Christopher James Foti

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Leonid A. Margulis

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Timothy D. White

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Robert L. Hendrickson

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Thomas Arthus Morris

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Timothy Norris

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Lynne A. Handanyan

Pfizer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge